1-3 of 3
Marissa Vignali, PhD
Close
Sort by
Journal Articles

Day 90 Post-Allogeneic Hematopoietic Cell Transplantation T Cell Receptor Diversity Level Correlates with Risk of Relapse in Patients with Multiple Myeloma

Robert Korngold, PhD, Kira Goldgirsh, MS, Themba Nyirenda, PhD, Phyllis McKiernan, APN, MSN, Ryan Emerson, PhD, Marissa Vignali, PhD, Julie Rubinstein, Harlan Robins, PhD, David Siegel, MD PhD, Michele L. Donato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4506.
https://doi.org/10.1182/blood.V130.Suppl_1.4506.4506
Published: 2017
Journal Articles

Next-Generation Sequencing Based Monitoring of Circulating-Tumor DNA in Untreated Peripheral T-Cell Lymphoma

Christopher Melani, MD, Stefania Pittaluga, MD PhD, Lydia Yee, CRNP, Andrea Lucas, RN, Margaret Shovlin, RN, Allison Jacob, MS, Kenneth Chan, PhD, Marissa Vignali, PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD PhD, Mark Roschewski, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2728.
https://doi.org/10.1182/blood.V130.Suppl_1.2728.2728
Published: 2017
Journal Articles

Integrated Immunological Analysis of the Bone Marrow Tumor Microenvironment in Myeloproliferative Neoplasms to Determine Potential Efficacy of Immune Checkpoint Blockade

Robert Orlowski, MD, Alexander Huang, Mercy Gohil, James Mangan, MD PhD, Marissa Vignali, PhD, Ryan O Emerson, PhD, Harlan Robins, PhD, Erik Yusko, PhD, Martha S Jordan, PhD, Martin Carroll, MD, D. Gary Gilliland, MD PhD, Elizabeth O Hexner, MD
Journal: Blood
Blood (2015) 126 (23): 2766.
https://doi.org/10.1182/blood.V126.23.2766.2766
Published: 2015